Clinical Practice Guidelines for Fecal Microbiota Transplantation in Korea

Gweon, Tae‐Geun; Lee, Yoo Jin; Kim, Kyeong Ok; Yim, Sung Kyun; Soh, Jae Seung; Kim, Seung Young; Park, Sung Chul; Shin, Seung Yong; Lee, Tae Hee; Choi, Chang Hwan; Cho, Young-Seok; Yong, Dongeun; Chung, Jin-Won; Lee, Kwang Jae; Lee, Oh Young; Choi, Moon-Gi; Choi, Miyoung

doi:10.5056/jnm21221

Cited by 18 publications

(25 citation statements)

References 109 publications

(219 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Clarification of document distinctions is provided in Table 1. [2][3][4]12,13,[24][25][26][27] As an example of the differences in readability and target reading ages between lay summaries and PLS, selected excerpts 28,29 showed the readability consensus was 12-14 years old for the lay summaries and 18-19 years old for the PLS (Figure 1, 28 Figure 2 29 ).…”

Section: Document Distinctions and Example Readability Comparisonsmentioning

confidence: 99%

“…Most medical publishers have endorsed the International Committee of Medical Journal Editors (ICMJE) recommendations on data sharing. [25][26] Authors of articles that report clinical trials must submit a data sharing statement with their manuscript and, for all trials that began enrolment after January 1, 2019, they must also include a data sharing plan when registering the trial.…”

Section: Fair Principles In Medical Publishingmentioning

confidence: 99%

“…Australia, Austria, Canada, Czechia, Denmark, Poland, Romania, South Korea, and the United Kingdom). [18][19][20][21][22][23][24][25][26] How ever, these guidelines are mostly an expert consensus of medical societies without the point of view of relevant regulatory authorities.…”

Section: Physicians' Approvalmentioning

confidence: 99%

See 2 more Smart Citations

Untitled

2022

Med Writ

View full text Add to dashboard Cite

bench to the bedside. The logical next step is understandability in its broadest sense -ensuring that research findings are published in a way that can be understood as widely as possible.In our second article, Shalini Dwivedi and Vidhi Vashisht describe open access initiatives from a range of stakeholders and review the growing importance of plain language summaries (PLSs) in improving the transparency of medical research.The growing importance of com muni cating research in widely understandable language is reflected in the development of different document types for different purposes. Sarah Griffiths and colleagues review the varied terminology used to describe the three main types of document communicating in accessible language and chnage to make a case for harmonisation.Even with immediate open access to research results in understandable language, people with disabilities face unique barriers to information access. The author Jeffry Ricker, who is completely blind, explains how he faces obstacles every day owing, in part, to electronic documents designed primarily for those with vision. He also provides practical tips and resources for medical writers on writing for people with disabilities.Data sharing is an important principle of open science that has powerful potential to increase trust in published research. For medical research, ethical considerations place important constraints on the sharing of patient data, and Eniola Awodiya and Joana Osório evaluate how pharma ceutical companies are seeking to strike the right balance between patient privacy and transparency.Being free to access is of no value if content is not discoverable. The term grey literature is used to describe a wide range of different information that is produced outside traditional publishing and distribution channels. Typically, a lack of indexing or tagging with uniform metadata means that the grey literature is not easily discoverable. In our fifth article, Toby Green delivers a call to action to medical writers and communicators to engage with these rich and diverse sources of information.

show abstract

Section: Document Distinctions and Example Readability Comparisonsmentioning

confidence: 99%

Section: Fair Principles In Medical Publishingmentioning

confidence: 99%

See 1 more Smart Citation

Untitled

2022

Med Writ

View full text Add to dashboard Cite

show abstract

Section: Physicians' Approvalmentioning

confidence: 99%

“All that is gold does not glitter”: Faecal microbiota transplantation

Kubátová¹

2022

Med Writ

View full text Add to dashboard Cite

“…Because FMT provides a rapid resolution of CDI and is associated with a lower recurrence compared with conventional treatment [ 6 ], it is recommended for recurrent or refractory CDI [ 1 , 7 , 8 ]. The process of FMT includes patients selection (= FMT indication), donor screening, stool processing, and fecal microbiota administration.…”

Section: Introductionmentioning

confidence: 99%

Recognition and attitudes of Korean physicians toward fecal microbiota transplantation: a survey study

Gweon

Lee

Yim

et al. 2023

Korean J Intern Med

Self Cite

View full text Add to dashboard Cite

Background/Aims: Fecal microbiota transplantation (FMT) represents a treatment option for recurrent Clostridioides difficile infection (CDI). Recently, FMT has been investigated in various clinical settings other than CDI. This study examined Korean physicians' recognition of FMT and their attitudes toward this procedure Methods: An online questionnaire included questions on indications for FMT, the FMT process, physicians' attitudes toward FMT for the treatment of CDI and non-CDI diseases, and possible concerns. Results: Finally, 107 physicians responded to this survey: 66 (61.7%) had experience of performing FMT, and 86 (80.4%) replied that they were willing to perform FMT for CDI. Two-thirds of physicians (63.6%, n = 68) would perform FMT for recurrent CDI on patients who had at least three recurrences. The most common obstacle to performing FMT for the treatment of CDI was the lack of regulations or guidelines (55.1%, n = 59). Seventy-seven (72.0%) physicians would consider FMT for non-CDI diseases when conventional treatment had failed. The most common obstacle for FMT for the treatment of non-CDI diseases was low treatment efficacy (57.0%, n = 61). Conclusions: Two-thirds of Korean physicians had experience of performing FMT, and many performed FMT for recurrent CDI. The results of this study will prove useful to researchers and practitioners in FMT in Korea.

show abstract

Clinical Practice Guidelines for Fecal Microbiota Transplantation in Korea

Cited by 18 publications

References 109 publications

Untitled

Untitled

“All that is gold does not glitter”: Faecal microbiota transplantation

Recognition and attitudes of Korean physicians toward fecal microbiota transplantation: a survey study

Contact Info

Product

Resources

About